TODD N SMITH

CIK 1523672 · Director, Pres & CEO · last filed 2020-05-22

TODD N SMITH is a Director, Pres & CEO who has filed 15 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for ASRT, was dated May 22, 2020. Across all open-market trades the lifetime net is −$94.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.16M

Companies

3

Total Filings

15

Lifetime Open-Market Net

-$94.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ASRT Director, Pres & CEO 644,925 $23.50 $15.16M $0 1 2020-05-22
Horizon Therapeutics Public Ltd Co (HZNP) Delisted EVP & Chief Commercial Officer 54,711 $116.30 $6.36M -$94.8K 8 2015-02-04
IVERIC bio, Inc. (OPHT) Delisted SVP & CCO $0 2 2015-01-06

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-05-22 ASRT Grant (A) +644,925 $0 EDGAR
2020-05-21 Disp (D) −365,500 $0
2020-03-05 Grant (A) +165,500 $0
2020-01-02 Grant (A) $0
2019-10-24 Grant (A) +200,000 $0
2015-02-04 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Exer (M) +13,750 $0 EDGAR
2015-01-06 IVERIC bio, Inc. (OPHT) Delisted Grant (A) $0 EDGAR
2014-10-07 IVERIC bio, Inc. (OPHT) Delisted Grant (A) $0 EDGAR
2014-09-22 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Grant (A) +54,138 $0 EDGAR
2014-09-22 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Disp (D) −54,138 $0 EDGAR
Showing 110 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.